Inventor
C. David Pendleton
Inventor
Bethesda, MD, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C07KPeptides23%
C12NMicroorganisms or enzymes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
Y02ATechnologies for adaptation to climate change12%
PatentTitleYear
7,094,405'Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients'20066,685,944'Modified HCV peptide vaccines'20046,294,322'Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1'20016,214,347'Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1'20015,976,541'Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope'19995,336,758'Peptides stimulating cytotoxic T cells immune to HIV RT'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2006Patents assigned to US HEALTH (6)· patent assignee history
1994–2006Based in Bethesda, MD, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| US HEALTH | 6 | 1994–2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bethesda, Maryland, US | 6 | 1994–2006 |